Clinical trial
Fase IV Clinical Trial to Evaluate Chondroitin Sulphate Efficacy and Safety in Patients With Knee Osteoarthritis and Psoriasis
NCT00669123 is registered in ClinicalTrials.gov with Bioiberica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fase IV Clinical Trial to Evaluate Chondroitin Sulphate Efficacy and Safety in Patients With Knee Osteoarthritis and Psoriasis
- Lead sponsor
- Bioiberica
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 126 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
joint diseases, muskuloskeletal diseases, osteoarthritis, psoriasis, skin diseases